relapsed acute lymphoblastic leukemia

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)

Active, not recruiting
  • Lymphoid Leukemia
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Miami (Pevonedistat, Vincristine,

Completed
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Miami, Florida
    University of Miami
Oct 19, 2022

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

Not yet recruiting
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 23, 2022

Acute Lymphoblastic Leukemia, Pediatric, Relapsed Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in

Recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • +2 more
  • Stanford, California
    Lucile Packard Children's Hospital Stanford
Sep 20, 2021

Relapsed Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Shenzhen (CD19 CART)

Unknown status
  • Relapsed Acute Lymphoblastic Leukemia
  • Refractory Acute Lymphoblastic Leukemia
  • CD19 CART
  • Shenzhen, China
    Shenzhen University General Hospital
Jul 7, 2019

Relapsed Acute Lymphoblastic Leukemia, Allergy to PEG e.Coli Asparaginase, Allergy to Native e.Coli Asparaginase Trial in Los

Terminated
  • Relapsed Acute Lymphoblastic Leukemia
  • +2 more
  • Los Angeles, California
    Childrens Hospital Los Angeles
Oct 2, 2018

Relapsed Acute Lymphoblastic Leukemia, Relapsed Acute Myelogenous Leukemia Trial in United States (GNKG168)

Terminated
  • Relapsed Acute Lymphoblastic Leukemia
  • Relapsed Acute Myelogenous Leukemia
  • Phoenix, Arizona
  • +28 more
Nov 22, 2015